SCMFMDA: Predicting microRNA-disease associations based on similarity constrained matrix factorization
- PMID: 34252084
- PMCID: PMC8345837
- DOI: 10.1371/journal.pcbi.1009165
SCMFMDA: Predicting microRNA-disease associations based on similarity constrained matrix factorization
Abstract
miRNAs belong to small non-coding RNAs that are related to a number of complicated biological processes. Considerable studies have suggested that miRNAs are closely associated with many human diseases. In this study, we proposed a computational model based on Similarity Constrained Matrix Factorization for miRNA-Disease Association Prediction (SCMFMDA). In order to effectively combine different disease and miRNA similarity data, we applied similarity network fusion algorithm to obtain integrated disease similarity (composed of disease functional similarity, disease semantic similarity and disease Gaussian interaction profile kernel similarity) and integrated miRNA similarity (composed of miRNA functional similarity, miRNA sequence similarity and miRNA Gaussian interaction profile kernel similarity). In addition, the L2 regularization terms and similarity constraint terms were added to traditional Nonnegative Matrix Factorization algorithm to predict disease-related miRNAs. SCMFMDA achieved AUCs of 0.9675 and 0.9447 based on global Leave-one-out cross validation and five-fold cross validation, respectively. Furthermore, the case studies on two common human diseases were also implemented to demonstrate the prediction accuracy of SCMFMDA. The out of top 50 predicted miRNAs confirmed by experimental reports that indicated SCMFMDA was effective for prediction of relationship between miRNAs and diseases.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
MDSCMF: Matrix Decomposition and Similarity-Constrained Matrix Factorization for miRNA-Disease Association Prediction.Genes (Basel). 2022 Jun 6;13(6):1021. doi: 10.3390/genes13061021. Genes (Basel). 2022. PMID: 35741782 Free PMC article.
-
Graph regularized L2,1-nonnegative matrix factorization for miRNA-disease association prediction.BMC Bioinformatics. 2020 Feb 18;21(1):61. doi: 10.1186/s12859-020-3409-x. BMC Bioinformatics. 2020. PMID: 32070280 Free PMC article.
-
MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction.PLoS Comput Biol. 2018 Aug 24;14(8):e1006418. doi: 10.1371/journal.pcbi.1006418. eCollection 2018 Aug. PLoS Comput Biol. 2018. PMID: 30142158 Free PMC article.
-
Review of MiRNA-Disease Association Prediction.Curr Protein Pept Sci. 2020;21(11):1044-1053. doi: 10.2174/1389203721666200210102751. Curr Protein Pept Sci. 2020. PMID: 32039677 Review.
-
Research progress of miRNA-disease association prediction and comparison of related algorithms.Brief Bioinform. 2022 May 13;23(3):bbac066. doi: 10.1093/bib/bbac066. Brief Bioinform. 2022. PMID: 35246678 Review.
Cited by
-
Hessian Regularized [Formula: see text]-Nonnegative Matrix Factorization and Deep Learning for miRNA-Disease Associations Prediction.Interdiscip Sci. 2024 Mar;16(1):176-191. doi: 10.1007/s12539-023-00594-8. Epub 2023 Dec 15. Interdiscip Sci. 2024. PMID: 38099958
-
GDCL-NcDA: identifying non-coding RNA-disease associations via contrastive learning between deep graph learning and deep matrix factorization.BMC Genomics. 2023 Jul 27;24(1):424. doi: 10.1186/s12864-023-09501-3. BMC Genomics. 2023. PMID: 37501127 Free PMC article.
-
bSRWPSO-FKNN: A boosted PSO with fuzzy K-nearest neighbor classifier for predicting atopic dermatitis disease.Front Neuroinform. 2023 Jan 16;16:1063048. doi: 10.3389/fninf.2022.1063048. eCollection 2022. Front Neuroinform. 2023. PMID: 36726405 Free PMC article.
-
Gaussian bare-bone slime mould algorithm: performance optimization and case studies on truss structures.Artif Intell Rev. 2023 Jan 20:1-37. doi: 10.1007/s10462-022-10370-7. Online ahead of print. Artif Intell Rev. 2023. PMID: 36694615 Free PMC article.
-
Exploring the effects of drug, disease, and protein dependencies on biomedical named entity recognition: A comparative analysis.Front Pharmacol. 2022 Dec 21;13:1020759. doi: 10.3389/fphar.2022.1020759. eCollection 2022. Front Pharmacol. 2022. PMID: 36618912 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
